Declaración conjunta en la continuación del período de sesiones de la CND: la pena de muerte por delitos relacionados con drogas

Publicaciones

Declaración conjunta en la continuación del período de sesiones de la CND: la pena de muerte por delitos relacionados con drogas

16 diciembre 2015
World Coalition Against the Death Penalty
Harm Reduction International (HRI)
Amnesty International

Varias organizaciones de derechos humanos, entre las cuales el IDPC y Reducción de Daños Internacional (HRI), han emitido una declaración conjunta que insta a los Estados miembros de la ONU a promover la abolición de la pena de muerte por los delitos relacionados con drogas en la próxima UNGASS de 2016. Más información, en inglés, está disponible abajo.

Suscríbase a las Alertas mensuales del IDPC para recibir información sobre cuestiones relacionadas con políticas sobre drogas.

We, the undersigned organisations, oppose the death penalty in all cases without exception and under all circumstances. Within the context of drug policies, and in light of the forthcoming UN General Assembly Special Session on drugs to be held in April 2016, we call on States to:

• Take immediate measures to halt executions, commute death sentences, and abolish the death penalty for drug-related offences as a first step towards its full abolition.
• Promote the abolition of the death penalty, including for drug-related offences, and the implementation of effective and evidence-based drugs policies that respect and protect human dignity, the rule of law and human rights.
• Ensure that drug policies and programmes are implemented in full compliance with international law and standards and that programmes to implement the UN Drug Conventions do not contribute to the use of the death penalty.
• Ensure transparency with regards to death sentences and executions.
• Request UNODC to conduct an annual review of the implementation of its human rights guidance in States receiving programmatic funding, the findings of which should be published annually to the CND by the Executive Director.

Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert